Robert Ticktin

Robert Ticktin

General Counsel & Chief Operating OfficeratPMV Pharmaceuticals· In the 2025 proxy

Pay in FY2025PMV Pharmaceuticals stock -17.2% the same year

Robert Ticktin was paid $861.2K in FY2025 (Dec). PMV Pharmaceuticals stock fell 17.2% that year.

Pay$100 in the stock at the end of FY24 → $83
Pay is from the Summary Compensation Table of each PMV Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PMV PharmaceuticalsPublic company · 1 yr
    • General Counsel & Chief Operating Officer2025 – Present · 1 yrStock in role -6%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?